Independent Research GmbH set a €105.00 ($123.53) price objective on Merck KGaA (FRA:MRK) in a report published on Thursday morning. The firm currently has a neutral rating on the healthcare company’s stock.

Several other equities research analysts also recently issued reports on MRK. J P Morgan Chase & Co reaffirmed a neutral rating on shares of Merck KGaA in a research report on Wednesday, June 7th. Commerzbank Ag set a €109.00 ($128.24) price target on Merck KGaA and gave the company a neutral rating in a research report on Tuesday, June 13th. Morgan Stanley set a €103.00 ($121.18) price target on Merck KGaA and gave the company a neutral rating in a research report on Tuesday, June 13th. Warburg Research set a €116.00 ($136.47) price target on Merck KGaA and gave the company a neutral rating in a research report on Tuesday, June 20th. Finally, equinet AG set a €112.00 ($131.76) price target on Merck KGaA and gave the company a neutral rating in a research report on Monday, June 26th. Thirteen investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Merck KGaA has an average rating of Hold and a consensus price target of €109.43 ($128.75).

Merck KGaA (FRA MRK) opened at 96.10 on Thursday. The firm has a market cap of €41.78 billion and a PE ratio of 25.05. Merck KGaA has a 1-year low of €89.00 and a 1-year high of €115.00. The company has a 50 day moving average price of €94.96 and a 200 day moving average price of €101.83.

TRADEMARK VIOLATION NOTICE: This article was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this article can be accessed at https://www.watchlistnews.com/independent-research-gmbh-analysts-give-merck-kgaa-mrk-a-105-00-price-target/1618586.html.

Merck KGaA Company Profile

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with Analyst Ratings Network's FREE daily email newsletter.